The role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: Uncertainty prevails

Annals of Surgical Oncology

Volumn 21, Issue 5, 2014, Pages 1517-1519

  Thompson, John F ^a,c,d   Hruby, George ^b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Department of Radiation Oncology Lifehouse ^*  (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EDITORIAL; HUMAN; MERKEL CELL TUMOR; SENTINEL LYMPH NODE BIOPSY; UNCERTAINTY; FEMALE; MALE; MORTALITY;

CARCINOMA, MERKEL CELL; FEMALE; HUMANS; MALE; SENTINEL LYMPH NODE BIOPSY;

EID: 84898895956     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3587-8     Document Type: Editorial

References (15)

1. Kachare SD, Wong JH, Vohra NA, et al. Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma. Ann Surg Oncol. 2013; doi: 10.1245/s10434-013-3434-3.
2. Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: Analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529-37.
3. Fritsch VA, Camp ER, Lentsch EJ. Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival. Head Neck. 2014; doi: 10.1002/hed.23334.
4. Warner RE, Quinn MJ, Hruby G, et al. Management of merkel cell carcinoma: The roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008;15:2509-18.
5. Howle J, Veness M. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience. Australas J Dermatol. 2012;53:26-31.
6. Maza S, Trefzer U, Hofmann M, et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006;33:433-40.
7. Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg. 2002;110:1259-65.
8. Rodrigues LK, Leong SP, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol. 2001;45:303-8. (Pubitemid 32729319)
9. Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol. 2003;21:4371-6. (Pubitemid 46621814)
10. Poulsen M, Walpole E, Harvey J, et al. Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin. Int J Radiat Oncol Biol Phys. 2008;72:1070-4.
11. Finnigan R, Hruby G, Wratten C, et al. The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma-a TROG substudy. Int J Radiat Oncol Biol Phys. 2013;86:91-5.
12. Sundaresan P, Hruby G, Hamilton A, et al. Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. Clin Oncol (R Coll Radiol). 2012;24:e131-6.
13. Veness M, Foote M, Gebski V, et al. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703-9.
14. Fang LC, Lemos B, Douglas J, et al. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma. Cancer. 2010;116:1783-90.
15. Siva S, Byrne K, Seel M, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: A 15 year institutional experience. J Nucl Med. 2013;54:1223-9.